Wells Fargo & Company Teva Pharmaceutical Industries LTD Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Wells Fargo & Company holds 900,894 shares of TEVA stock, worth $19.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
900,894
Previous 975,960 7.69%
Holding current value
$19.9 Million
Previous $15.9 Million 2.36%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$15.81 - $18.96 $1.19 Million - $1.42 Million
-75,066 Reduced 7.69%
900,894 $16.2 Million
Q2 2024

Aug 13, 2024
BUY
$12.78 - $17.4 $648,469 - $882,893
50,741 Added 5.48%
975,960 $15.9 Million
Q1 2024

May 10, 2024
BUY
$10.67 - $14.43 $6.76 Million - $9.14 Million
633,659 Added 217.33%
925,219 $13.1 Million
Q4 2023

Feb 09, 2024
SELL
$8.12 - $10.63 $169,480 - $221,869
-20,872 Reduced 6.68%
291,560 $3.04 Million
Q3 2023

Nov 13, 2023
BUY
$7.48 - $10.7 $90,605 - $129,609
12,113 Added 4.03%
312,432 $3.19 Million
Q2 2023

Aug 15, 2023
SELL
$7.2 - $9.47 $1.22 Million - $1.6 Million
-169,034 Reduced 36.01%
300,319 $2.26 Million
Q1 2023

May 12, 2023
SELL
$8.36 - $11.37 $1.13 Million - $1.53 Million
-134,623 Reduced 22.29%
469,353 $4.15 Million
Q4 2022

Feb 13, 2023
BUY
$7.95 - $9.48 $1.95 Million - $2.33 Million
245,749 Added 68.6%
603,976 $5.51 Million
Q3 2022

Nov 14, 2022
SELL
$6.86 - $11.95 $250,088 - $435,649
-36,456 Reduced 9.24%
358,227 $2.89 Million
Q2 2022

Aug 12, 2022
BUY
$7.38 - $10.4 $645,218 - $909,251
87,428 Added 28.45%
394,683 $2.97 Million
Q1 2022

May 16, 2022
SELL
$7.33 - $9.39 $272,199 - $348,697
-37,135 Reduced 10.78%
307,255 $2.89 Million
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $119,155 - $153,695
15,083 Added 4.58%
344,390 $2.76 Million
Q3 2021

Nov 15, 2021
SELL
$8.38 - $10.18 $2.16 Million - $2.62 Million
-257,635 Reduced 43.89%
329,307 $3.21 Million
Q2 2021

Aug 16, 2021
BUY
$9.9 - $11.56 $1.48 Million - $1.73 Million
149,407 Added 34.15%
586,942 $5.81 Million
Q1 2021

May 13, 2021
BUY
$10.34 - $12.81 $568,245 - $703,986
54,956 Added 14.36%
437,535 $5.05 Million
Q4 2020

Feb 09, 2021
SELL
$8.61 - $11.04 $820,395 - $1.05 Million
-95,284 Reduced 19.94%
382,579 $3.69 Million
Q3 2020

Nov 05, 2020
SELL
$8.57 - $12.69 $569,545 - $843,352
-66,458 Reduced 12.21%
477,863 $4.31 Million
Q2 2020

Aug 13, 2020
SELL
$8.12 - $13.12 $4.7 Million - $7.6 Million
-579,264 Reduced 51.55%
544,321 $6.71 Million
Q1 2020

May 14, 2020
BUY
$6.69 - $13.45 $7.52 Million - $15.1 Million
1,123,585 New
1,123,585 $10.1 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email